WT-CLS1 Cells
US$ 650,00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
Informações gerais
| Descrição | The WT-CLS1 cell line was established from a primary Wilms’ tumor by CLS in 1998. However, the cells have rhabdoid characteristics, as demonstrated by E. Kunce Stroup et al. in 2017. WT-CLS1 cells are sensitive to miR-16, as a result cyclin D genes expression decreases. In addition, the cells showed a unique resistance to IGF1R inhibition, in contrast to true Wilm’s tumor cells. |
|---|---|
| Organismo | Human |
| Tecido | Kidney |
| Doença | Rhabdoid tumor |
| Sinônimos | CLS1 |
Características
| Idade | 5 years |
|---|---|
| Gênero | Female |
| Etnia | Caucasian |
| Morfologia | Epithelial-like |
| Tipo de célula | B lymphoblast |
| Propriedades de crescimento | Monolayer, adherent |
Dados regulatórios
| Referência | WT-CLS1 (Cytion catalog number 300379) |
|---|---|
| Nível de biossegurança | 1 |
| NCBI_TaxID | 9606 |
| Número de acesso do Cellosaurus | CVCL_5904 |
Dados biomoleculares
| Tumorigênico | Yes, in nude mice. Forms tumor with small cells consistent with Wilms' tumor (xenografts may not represent Wilm’s tumors completely, see E. Kunce Stroup 2017) |
|---|---|
| Vírus | HIV-1: negative, HBV: negative, HCV: negative |
| Perfil mutacional | WT1 mutation status: wild type, CTNNB1 mutation status: wild type, no LOH. |
Manuseio
| Meio de cultura | IMDM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 25 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 3.024 g/L NaHCO3 (Cytion article number 820800a) |
|---|---|
| Suplementos | Supplement the medium with 10% FBS |
| Reagente de dissociação | Accutase |
| Subcultura | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Densidade de semeadura | 1 to 3 x 105 cells/cm2 |
| Renovação de fluidos | Every 3 to 4 days |
| Meio de congelamento | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Descongelamento e cultura de células |
|
| Atmosfera de incubação | 37°C, 5% CO2, humidified atmosphere. |
| Condições de envio | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Condições de armazenamento | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Controle de Qualidade e Análise Molecular
| Esterilidade | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificado de Análise (CoA)
| Número do lote | Tipo de certificado | Data | Número de catálogo |
|---|---|---|---|
| 300379-614SF | Certificado de Análise | 23. May. 2025 | 300379 |